Objectives: Endothelial dysfunction is involved in the development of the acute coronary syndrome (ACS). Plasma microparticles (MPs) from other diseases have been demonstrated to initiate coagulation and endothelial dysfunction. However, whether MPs from ACS patients impair vasodilatation and endothelial function remains unclear. Methods: Patients (n = 62) with ACS and healthy controls (n = 30) were recruited for MP isolation. Rat thoracic aortas were incubated with MPs from ACS patients or healthy controls to determine the effects of MPs on endothelial-dependent vasodilatation, the phosphorylation of Akt and endothelial nitric oxide synthase (eNOS), the interaction of eNOS with heat shock protein 90 (Hsp90), and nitric oxide (NO) and superoxide anion (O2-) production. The origin of MPs was assessed by flow cytometry. Results: MP concentrations were increased in patients with ACS compared with healthy controls. They were positively correlated with the degree of coronary artery stenosis. MPs from ACS patients impair endothelial-dependent vasodilatation, decrease both Akt and eNOS phosphorylation, decrease the interaction between eNOS and Hsp90, and decrease NO production but increase O2- generation in rat thoracic aortas. Endothelial-derived MPs and platelet-derived MPs made up nearly 75% of MPs. Conclusions: Our data indicate that MPs from ACS patients negatively affect endothelial-dependent vasodilatation via Akt/eNOS-Hsp90 pathways.

Keywords:
Acute coronary syndrome, Endothelial dysfunction, Endothelial cells, Endothelium-dependent relaxation, Inflammation, Vasodilation
1.
Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002;105:1135-1143.
2.
Kristensen SD, Ravn HB, Falk E: Insights into the pathophysiology of unstable coronary artery disease. Am J Cardiol 1997;80:5E-9E.
3.
Freedman JE, Loscalzo J: Nitric oxide and its relationship to thrombotic disorders. J Thromb Haemost 2003;1:1183-1188.
4.
Mujumdar VS, Aru GM, Tyagi SC: Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem 2001;82:491-500.
5.
Paredes-Gamero EJ, Medeiros VP, Lima MA, Accardo CM, Farias EH, Sassaki GI, Campana PT, Miranda A, Ferreira AT, Tersariol IL, Nader HB: Chemical reduction of carboxyl groups in heparin abolishes its vasodilatory activity. J Cell Biochem 2012;113:1359-1367.
6.
Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-1051.
7.
Peterson DB, Sander T, Kaul S, Wakim BT, Halligan B, Twigger S, Pritchard KA Jr, Oldham KT, Ou JS: Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. Proteomics 2008;8:2430-2446.
8.
Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, Eschwege V, Hedman H, Freyssinet JM: Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 1994;153:3245-3255.
9.
Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R: Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 2005;288:H1004-H1009.
10.
Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ: Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989;264:17049-17057.
11.
Huber J, Vales A, Mitulovic G, Blumer M, Schmid R, Witztum JL, Binder BR, Leitinger N: Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol 2002;22:101-107.
12.
Gasser O, Hess C, Miot S, Deon C, Sanchez JC, Schifferli JA: Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res 2003;285:243-257.
13.
Klinkner DB, Densmore JC, Kaul S, Noll L, Lim HJ, Weihrauch D, Pritchard KA Jr, Oldham KT, Sander TL: Endothelium-derived microparticles inhibit human cardiac valve endothelial cell function. Shock 2006;25:575-580.
14.
Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V: Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 2002;160:673-680.
15.
Horstman LL, Jy W, Jimenez JJ, Ahn YS: Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004;9:1118-1135.
16.
Owens AP 3rd, Mackman N: Microparticles in hemostasis and thrombosis. Circ Res 2011;108:1284-1297.
17.
Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A, Boulanger CM: Microparticles, vascular function, and atherothrombosis. Circ Res 2011;109:593-606.
18.
Biasucci LM, Porto I, Di Vito L, De Maria GL, Leone AM, Tinelli G, Tritarelli A, Di Rocco G, Snider F, Capogrossi MC, Crea F: Differences in microparticle release in patients with acute coronary syndrome and stable angina. Circ J 2012;76:2174-2182.
19.
Chen YH, Liu JM, Hsu RJ, Hu SC, Harn HJ, Chen SP, Jeng JR, Wu CL, Ho JY, Yu CP: Angiotensin converting enzyme DD genotype is associated with acute coronary syndrome severity and sudden cardiac death in Taiwan: a case-control emergency room study. BMC Cardiovasc Disord 2012;12:6.
20.
Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z: Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001;104:2649-2652.
21.
Ketonen J, Mervaala EMA: Effects of dietary sodium on ROS formation and endothelial dysfunction in LDL receptor-deficient mice on high fat diet. Heart Vessels 2008;23:420-429.
22.
Ketonen J, Merasto S, Paakkari I, Mervaala EM: High sodium intake increases vascular superoxide formation and promotes atherosclerosis in apolipoprotein E-deficient mice. Blood Press 2005;14:373-382.
23.
Ci HB, Ou ZJ, Chang FJ, Liu DH, He GW, Xu Z, Yuan HY, Wang ZP, Zhang X, Ou JS: Endothelial microparticles increase in mitral valve disease and impair mitral valve endothelial function. Am J Physiol Endocrinol Metab 2013;304:695-702.
24.
Bernal-Mizrachi L, Jy W, Fierro C, Macdonough R, Velazques HA, Purow J, Jimenez JJ, Horstman LL, Ferreira A, de Marchena E, Ahn YS: Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol 2004;97:439-446.
25.
Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL, de Marchena E, Ahn YS: High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003;145:962-970.
26.
Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS: Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 2004;286:H1910-H1915.
27.
Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A: Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009;101:439-451.
28.
Densmore JC, Signorino PR, Ou J, Hatoum OA, Rowe JJ, Shi Y, Kaul S, Jones DW, Sabina RE, Pritchard KA Jr, Guice KS, Oldham KT: Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury. Shock 2006;26:464-471.
29.
Ou ZJ, Chang FJ, Luo D, Liao XL, Wang ZP, Zhang X, Xu YQ, Ou JS: Endothelium-derived microparticles inhibit angiogenesis in the heart and enhance the inhibitory effects of hypercholesterolemia on angiogenesis. Am J Physiol Endocrinol Metab 2011;300:E661-E668.
30.
Verma S, Buchanan MR, Anderson TJ: Endothelial function testing as a biomarker of vascular disease. Circulation 2003;108:2054-2059.
31.
Pan X, Zheng Z, Hu S, Li S, Wei Y, Zhang Y, Cheng X, Ma K: Mechanisms of pulmonary hypertension related to ventricular septal defect in congenital heart disease. Ann Thorac Surg 2011;92:2215-2220.
32.
Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999;399:597-601.
33.
Lu XL, Luo D, Yao XL, Wang GL, Liu ZY, Li ZX, Li W, Chang FJ, Wen L, Lee SM, Zhang ZJ, Li L, Zeng JS, Huang RX, Pei Z, Ou JS: dl-3n-Butylphthalide promotes angiogenesis via the extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase/Akt-endothelial nitric oxide synthase signaling pathways. J Cardiovasc Pharmacol 2012;59:352-362.
34.
Shi F, Wang YC, Zhao TZ, Zhang S, Du TY, Yang CB, Li YH, Sun XQ: Effects of simulated microgravity on human umbilical vein endothelial cell angiogenesis and role of the PI3K-Akt-eNOS signal pathway. PLoS One 2012;7:e40365.
35.
Palmer RMJ, Ashton DS, Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-666.
36.
Schumm J, Luetzkendorf S, Rademacher W, Franz M, Schmidt-Winter C, Kiehntopf M, Figulla HR, Brehm BR: In patients with aortic stenosis increased flow-mediated dilation is independently associated with higher peak jet velocity and lower asymmetric dimethylarginine levels. Am Heart J 2011;161:893-899.
37.
Heistad DH: Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2006;26:689-695.
38.
Pechánová O, Simko F: The role of nitric oxide in the maintenance of vasoactive balance. Physiol Res 2007;56(suppl 2):S7-S16.
39.
Stuehr D, Pou S, Rosen GM: Oxygen reduction by nitric oxide synthases. J Biol Chem 2001;276:14533-14536.
40.
Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Oqawa H: Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol 2009;54:601-608.
41.
Sinning JM, Losch J, Walenta K, Bohm M, Nickenig G, Werner N: Circulating CD31+/annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 2011;32:2034-2041.
42.
Christersson C, Johnell M, Siegbahn A: Evaluation of microparticles in whole blood by multicolour flow cytometry assay. Scand J Clin Lab Invest 2013;73:229-239.
43.
Nadaud S, Poirier O, Girerd B, Blanc C, Montani D, Eyries M, Imbert-Bismut F, Pacheco A, Vigne J, Tregouet DA, Humbert M, Soubrier F: Small platelet microparticle levels are increased in pulmonary arterial hypertension. Eur J Clin Invest 2013;43:64-71.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.